Related references
Note: Only part of the references are listed.Specific bile acids inhibit hepatic fatty acid uptake in mice
Biao Nie et al.
HEPATOLOGY (2012)
Garcinol, a Histone Acetyltransferase Inhibitor, Radiosensitizes Cancer Cells by Inhibiting Non-Homologous End Joining
Takahiro Oike et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications
Marcelo G. Roma et al.
CLINICAL SCIENCE (2011)
Cancer Chemoprevention by Targeting the Epigenome
Joseph Huang et al.
CURRENT DRUG TARGETS (2011)
In PSC with Colitis Treated with UDCA, Most Colonic Carcinomas Develop in the First Years After the Start of Treatment
G. Rudolph et al.
DIGESTIVE DISEASES AND SCIENCES (2011)
Primary Biliary Cirrhosis
Bhavik M. Bhandari et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2011)
Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men
Emma C. Thomson et al.
GUT (2011)
Evaluation of risk factors for the development of cirrhosis in autoimmune hepatitis: Japanese NHO-AIH prospective study
Kiyoshi Migita et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Solanum nigrum L. polyphenolic extract inhibits hepatocarcinoma cell growth by inducing G(2)/M phase arrest and apoptosis
Hsueh-Chun Wang et al.
JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2011)
A 35-year follow-up of a large cohort of patients with primary biliary cirrhosis seen at a single centre
Annarosa Floreani et al.
LIVER INTERNATIONAL (2011)
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis
Yury Popov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Linking long-term toxicity of xeno-chemicals with short-term biological adaptation
Robert Barouki
BIOCHIMIE (2010)
ΔNp73β is oncogenic in hepatocellular carcinoma by blocking apoptosis signaling via death receptors and mitochondria
Andre Schuster et al.
CELL CYCLE (2010)
Membrane Cholesterol Depletion by Methyl-beta-Cyclodextrin Enhances the Expression of Cardiac Differentiation Markers
Carolina Pontes Soares et al.
CELLS TISSUES ORGANS (2010)
Safety, Tolerability, and Cerebrospinal Fluid Penetration of Ursodeoxycholic Acid in Patients With Amyotrophic Lateral Sclerosis
Gareth J. Parry et al.
CLINICAL NEUROPHARMACOLOGY (2010)
Converging Perturbed Microvasculature and Microglial Clusters Characterize Alzheimer Disease Brain
N. Jantaratnotai et al.
CURRENT ALZHEIMER RESEARCH (2010)
Targeting the p53 Pathway of Apoptosis
Joana D. Amaral et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Ursodeoxycholic acid treatment in patients with cystic fibrosis at risk for liver disease
Maria Siano et al.
DIGESTIVE AND LIVER DISEASE (2010)
The Endogenous Selective Estrogen Receptor Modulator 27-Hydroxycholesterol Is a Negative Regulator of Bone Homeostasis
Carolyn D. DuSell et al.
ENDOCRINOLOGY (2010)
A concentration-dependent effect of ursodeoxycholate on apoptosis and caspases activities of HepG2 hepatocellular carcinoma cells
Nikos J. Tsagarakis et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Up-regulation of Kruppel-Like Factor 8 Promotes Tumor Invasion and Indicates Poor Prognosis for Hepatocellular Carcinoma
Jia-Chu Li et al.
GASTROENTEROLOGY (2010)
Targets for Current Pharmacologic Therapy in Cholesterol Gallstone Disease
Agostino Di Ciaula et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2010)
Bile Acid Changes After High-Dose Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis: Relation to Disease Progression
Emmanouil Sinakos et al.
HEPATOLOGY (2010)
High-Dose Ursodeoxycholic Acid Therapy for Nonalcoholic Steatohepatitis: A Double-Blind, Randomized, Placebo-Controlled Trial
Ulrich F. H. Leuschner et al.
HEPATOLOGY (2010)
Fluorescence imaging of membrane dynamics in living cells
Petra Weber et al.
JOURNAL OF BIOMEDICAL OPTICS (2010)
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival
Gerda Rudolph et al.
JOURNAL OF HEPATOLOGY (2010)
Critical role of lipid rafts in virus entry and activation of phosphoinositide 3' kinase/Akt signaling during early stages of Japanese encephalitis virus infection in neural stem/progenitor cells
Sulagna Das et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Hepatitis B and Hepatitis C Virus Replication Upregulates Serine Protease Inhibitor Kazal, Resulting in Cellular Resistance to Serine Protease-Dependent Apoptosis
Jason Lamontagne et al.
JOURNAL OF VIROLOGY (2010)
Mitochondrial gateways to cancer
Lorenzo Galluzzi et al.
MOLECULAR ASPECTS OF MEDICINE (2010)
Cyanobacterial Cyclopeptides as Lead Compounds to Novel Targeted Cancer Drugs
Ioannis Sainis et al.
MARINE DRUGS (2010)
PRIMARY SCLEROSING CHOLANGITIS What is the role of ursodeoxycholic acid in therapy for PSC?
Roger W. Chapman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Inflammation in Neurological Disorders: A Help or a Hindrance?
V. Wee Yong
NEUROSCIENTIST (2010)
Management of gallstones and gallbladder disease in patients undergoing gastric bypass
Bernabe M. Quesada et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Apoptosis and Modulation of Cell Cycle Control by Bile Acids in Human Leukemia T Cells
Carmela Fimognari et al.
NATURAL COMPOUNDS AND THEIR ROLE IN APOPTOTIC CELL SIGNALING PATHWAYS (2009)
Nuclear receptors as therapeutic targets in cholestatic liver diseases
Gernot Zollner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Gender Modifies the Effect of Ursodeoxycholic Acid in a Randomized Controlled Trial in Colorectal Adenoma Patients
Patricia A. Thompson et al.
CANCER PREVENTION RESEARCH (2009)
Role of Nuclear Steroid Receptors in Apoptosis
Joana Amaral et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Ursodeoxycholic Acid in Neonatal Hepatitis and Infantile Paucity of Intrahepatic Bile Ducts: Review of a Historical Cohort
M. A. Kotb
DIGESTIVE DISEASES AND SCIENCES (2009)
Predictors of Treatment Response in Chronic Hepatitis B
Grace L-H. Wong et al.
DRUGS (2009)
High-Dose Ursodeoxycholic Acid for the Treatment of Primary Sclerosing Cholangitis
Keith D. Lindor et al.
HEPATOLOGY (2009)
Primary biliary cirrhosis
Simon Hohenester et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Biochemical mechanisms in drug-induced liver injury: Certainties and doubts
Ignazio Grattagliano et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Bile-acid-induced cell injury and protection
Maria J. Perez et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Structural biology of the tumor suppressor p53
Andreas C. Joerger et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation
In. H. Park et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Nuclear factor-kB activation: From bench to bedside
Gautam Sethi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKCα-/PKA-dependent mechanism in rat liver
R. Wimmer et al.
GUT (2008)
Decreased number of activated macrophages in gallbladder muscle layer of cholesterol gallstone patients following ursodeoxycholic acid
M. P. L. Guarino et al.
GUT (2008)
A single centre experience of liver disease in adults with cystic fibrosis 1995-2006
K. L. Nash et al.
JOURNAL OF CYSTIC FIBROSIS (2008)
Acute hepatitis A virus infection in Turkey
Andrea Normann et al.
JOURNAL OF MEDICAL VIROLOGY (2008)
Review of historical cohort: ursodeoxycholic acid in extrahepatic biliary atresia
Magd A. Kotb
JOURNAL OF PEDIATRIC SURGERY (2008)
Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
Faisal M. Sanai et al.
LIVER INTERNATIONAL (2008)
Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: Roles of Ras, p38, and CCAAT/enhancer-binding protein
Sharad Khare et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
PUMA, a potent killer with or without p53
J. Yu et al.
ONCOGENE (2008)
Aldo-keto reductase 1C2 is essential for 1-nitropyrene's but not for benzo[a]pyrene's induction of p53 phosphorylation and apoptosis
Jyan-Gwo J. Su et al.
TOXICOLOGY (2008)
Bile acids and apoptosis modulation: an emerging role in experimental Alzheimer's disease
Rita M. Ramalho et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases
Michael Trauner et al.
WIENER MEDIZINISCHE WOCHENSCHRIFT (2008)
p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis
Joana D. Amaral et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Novel cytotoxic agents from an unexpected source: Bile acids and ovarian tumor apoptosis
Neil S. Horowitz et al.
GYNECOLOGIC ONCOLOGY (2007)
Increased age, male gender, and cirrhosis, but not steatosis or a positive viral serology, negatively impact the life expectancy of patients who undergo liver biopsy
Mitchell S. Wachtel et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes
Rui E. Castro et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation
Phunchai Charatcharoenwitthaya et al.
LIVER TRANSPLANTATION (2007)
Fibrogenic cell fate during fibrotic tissue remodelling observed in rat and human cultured liver slices
Christelle Guyot et al.
JOURNAL OF HEPATOLOGY (2007)
Integrating cell-signalling pathways with NF-kappa B and IKK function
Neil D. Perkins
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Cellular senescence: when bad things happen to good cells
Judith Campisi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Ursodeoxycholic acid modulates histone acetylation and induces differentiation and senescence
Sandeep Akare et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy
Matthew R. Ritter et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Introduction to NF-κB:: players, pathways, perspectives
T. D. Gilmore
ONCOGENE (2006)
Resistance to ursodeoxycholic acid-induced growth arrest can also result in resistance to deoxycholic acid-induced apoptosis and increased tumorgenicity
Ashley A. Powell et al.
BMC CANCER (2006)
Early treatment with ursodeoxycholic acid for cholestasis in children on parenteral nutrition because of primary intestinal failure
G. De Marco et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: A meta-analysis of randomized controlled trials
Jian Shi et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Unconjugated bilirubin activates and damages microglia
Ana C. Gordo et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Ursodeoxycholic acid in primary biliary cirrhosis improves glutathione status but fails to reduce lipid peroxidation
Philip W. Pemberton et al.
REDOX REPORT (2006)
Coordinated induction of bile acid detoxification and alternative elimination in mice:: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids
G Zollner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2006)
Role of nuclear receptors in the adaptive response to bile acids and cholestasis: Pathogenetic and therapeutic considerations
Gernot Zollner et al.
MOLECULAR PHARMACEUTICS (2006)
Oncogene-induced senescence: Putting the brakes on tumor development
M Braig et al.
CANCER RESEARCH (2006)
How does cellular senescence prevent cancer?
MD Lynch
DNA AND CELL BIOLOGY (2006)
Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice
P Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Enhancement of DNA topoisomerase I inhibitor-induced apoptosis by ursodeoxycholic acid
T Ikegami et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Blocking the path to death: Anti-apoptotic molecules in ischemia/reperfusion injury of the liver
P. Georgiev et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Microglial senescence: does the brain's immune system have an expiration date?
Wolfgang J. Streit
TRENDS IN NEUROSCIENCES (2006)
Modulation of hepatocyte apoptosis: Cross-talk between bile acids and nuclear steroid receptors
S. Sola et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Synthetic bile acid derivatives induce apoptosis through a c-Jun N-terminal kinase and NF-κB-dependent process in human cervical carcinoma cells
E Im et al.
CANCER LETTERS (2005)
Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-β1-induced apoptosis in rat hepatocytes
S Solá et al.
HEPATOLOGY (2005)
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence
DS Alberts et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Suppressive effect of ursodeoxycholic acid on type IIA phospholipase A2 expression in HepG2 cells
T Ikegami et al.
HEPATOLOGY (2005)
Inhibition of hepatocyte growth factor production in human fibroblasts by ursodeoxycholic acid
K Hiramatsu et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Ursodeoxycholic acid induced activation of the glucocorticoid receptor in primary rat hepatocytes
C Weitzel et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2005)
Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKB-dependent survival signaling
E Im et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2005)
Human breast cancer resistance protein: Interactions with steroid drugs, hormones, the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and transport of cimetidine
P Pavek et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Serum ALT levels as a surrogate marker for serum HBV DNA levels in HBeAg-negative pregnant women
P Sangfelt et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells
E Im et al.
JOURNAL OF NUTRITION (2004)
Prolonged follow-up of patients in the US multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis
B Combes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Unraveling V(D)J recombination: Insights into gene regulation
D Jung et al.
CELL (2004)
Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1
H Higuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Detoxification of lithocholic acid, a toxic bile acid: Relevance to drug hepatotoxicity
AF Hofmann
DRUG METABOLISM REVIEWS (2004)
Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2)
SS Joo et al.
ARCHIVES OF PHARMACAL RESEARCH (2004)
Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-β1-Induced E2F-1/p53-mediated apoptosis of rat hepatocytes
S Solá et al.
BIOCHEMISTRY (2004)
Downregulation of the antiapoptotic Mcl-1 protein and apoptosis in Ma-11 breast cancer cells induced by an anti-epidermal growth factor receptor-Pseudomonas exotoxin a immunotoxin
Y Andersson et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Role of mitochondrial dysfunction in combined bile acid-induced cytotoxicity: The switch between apoptosis and necrosis
AP Rolo et al.
TOXICOLOGICAL SCIENCES (2004)
Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor β1-induced apoptosis of rat hepatocytes
S Solá et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Ursodeoxycholic acid inhibits pro-inflammatory repertoires, IL-1β and nitric oxide in rat microglia
SS Joo et al.
ARCHIVES OF PHARMACAL RESEARCH (2003)
Phosphatidylserine receptor is required for clearance of apoptotic cells
MO Li et al.
SCIENCE (2003)
Puma is an essential mediator of p53-dependent and -independent apoptotic pathways
JR Jeffers et al.
CANCER CELL (2003)
Apoptosis and modulation of cell cycle control by synthetic derivatives of ursodeoxycholic acid and chenodeoxycholic acid in human prostate cancer cells
YH Choi et al.
CANCER LETTERS (2003)
Impact of drug transporter studies on drug discovery and development
N Mizuno et al.
PHARMACOLOGICAL REVIEWS (2003)
Primary sclerosing cholangitis in children: A long-term follow-up study
AE Feldstein et al.
HEPATOLOGY (2003)
Application of a human multidrug transporter (ABCG2) variant as selectable marker in gene transfer to progenitor cells
O Ujhelly et al.
HUMAN GENE THERAPY (2003)
The role of p53 in determining sensitivity to radiotherapy
AV Gudkov et al.
NATURE REVIEWS CANCER (2003)
DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation
CJ Bakkenist et al.
NATURE (2003)
Long-term survival and cause-specific mortality in patients with cirrhosis of the liver: a nationwide cohort study in Denmark
HT Sorensen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2003)
Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles
P Fickert et al.
GASTROENTEROLOGY (2002)
Ursodeoxycholic acid (UDCA) prevents DCA effects on male mouse liver via up-regulation of CXP and preservation of BSEP activities
M Paolini et al.
HEPATOLOGY (2002)
Nuclear transcription factor-κB as a target for cancer drug development
A Garg et al.
LEUKEMIA (2002)
Transcriptional repression of the anti-apoptotic survivin gene by wild type p53
WH Hoffman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cytokeratins as targets for bile acid-induced toxicity
P Fickert et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Functional modulation of the glucocorticoid receptor and suppression of NF-κB-dependent transcription by ursodeoxycholic acid
T Miura et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Micronuclei induction, cell cycle delay and apoptosis as markers of cellular stress caused by ursodeoxycholic acid in human lymphocytes
C Fimognari et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2001)
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'
KN Lazaridis et al.
JOURNAL OF HEPATOLOGY (2001)
Novel bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells
EO Im et al.
CANCER LETTERS (2001)
Glucocorticoid receptor homodimers and glucocorticoid-mineralcorticoid receptor heterodimers form in the cytoplasm through alternative dimerization interfaces
JGA Savory et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Epidemiology and natural history of primary biliary cirrhosis in a US community
WR Kim et al.
GASTROENTEROLOGY (2000)
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
C Corpechot et al.
HEPATOLOGY (2000)
Inhibition of Akt and its anti-apoptotic activities by tumor necrosis factor-induced protein kinase C-related kinase 2 (PRK2) cleavage
H Koh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Response-adjusted α-interferon therapy for chronic hepatitis C in HIV-infected patients
T Prestileo et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2000)
Long-term effects of ursodeoxycholic acid in primary biliary cirrhosis:: results of a double-blind controlled multicentric trial
A Parés et al.
JOURNAL OF HEPATOLOGY (2000)
Comparison of the effects of bile acids on cell viability and DNA synthesis by rat hepatocytes in primary culture
MC Martinez-Diez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2000)
Characterisation of patients with primary biliary cirrhosis responding to long term ursodeoxycholic acid treatment
M Leuschner et al.
GUT (2000)
Effects of ursodeoxycholic acid on splanchnic and systemic hemodynamics - A double-blind, cross-over, placebo-controlled study in healthy volunteers
P Schiedermaier et al.
DIGESTION (2000)
Share Paper
